Tony Butler

Stock Analyst at Rodman & Renshaw

(0.75)
# 4,024
Out of 5,045 analysts
97
Total ratings
32.35%
Success rate
-13.51%
Average return

Stocks Rated by Tony Butler

Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $14.05
Upside: +78.00%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.48
Upside: +343.55%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.33
Upside: +1,253.38%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.10
Upside: +614.29%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.46
Upside: +1,642.92%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.59
Upside: +2,602.70%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.29
Upside: +675.19%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $61.10
Upside: +22.75%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $95.06
Upside: -63.18%
GT Biopharma
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $0.63
Upside: +9,455.66%
Reiterates: Buy
Price Target: $13
Current: $1.65
Upside: +687.88%
Reiterates: Buy
Price Target: $50
Current: $8.76
Upside: +470.78%
Reiterates: Buy
Price Target: $15
Current: $1.21
Upside: +1,139.67%
Reiterates: Buy
Price Target: $25
Current: $0.69
Upside: +3,498.16%
Initiates: Buy
Price Target: $15
Current: $3.42
Upside: +338.60%
Reiterates: Buy
Price Target: $10
Current: $6.56
Upside: +52.56%
Reiterates: Buy
Price Target: $17
Current: $2.99
Upside: +468.56%
Reiterates: Buy
Price Target: $8.3$166
Current: $3.81
Upside: +4,256.96%
Reiterates: Buy
Price Target: $60
Current: $10.25
Upside: +485.37%
Reiterates: Buy
Price Target: $240
Current: $1.99
Upside: +11,960.30%
Assumes: Buy
Price Target: $6
Current: $0.44
Upside: +1,278.04%
Assumes: Buy
Price Target: $360
Current: $3.91
Upside: +9,107.16%
Maintains: Hold
Price Target: $5$2
Current: $5.76
Upside: -65.28%
Initiates: Buy
Price Target: $15
Current: $2.87
Upside: +422.65%
Downgrades: Neutral
Price Target: $30$10
Current: $0.99
Upside: +912.66%
Initiates: Buy
Price Target: $15
Current: $3.72
Upside: +303.23%
Maintains: Buy
Price Target: $80$110
Current: $12.27
Upside: +796.86%
Initiates: Buy
Price Target: $960
Current: $12.25
Upside: +7,736.73%